Literature DB >> 32251807

Risk Factors for Early Mortality in Patients with Primary Central Nervous System Lymphoma: A Large-Cohort Retrospective Study.

Xingwang Zhou1, Xiaodong Niu1, Junhong Li1, Shuxin Zhang1, Wanchun Yang1, Yuan Yang1, Qing Mao1, Yanhui Liu2.   

Abstract

OBJECTIVE: The present study assessed early mortality (within 1 and 3 months) in patients with primary central nervous system lymphoma (PCNSL) and identified the risk factors associated with early mortality.
METHODS: We extracted the data for patients with PCNSL from the Surveillance, Epidemiology, and End Results dataset using the SEER∗Stat, version 8.3.5, software.
RESULTS: A total of 8091 patients with PCNSL were enrolled in the present study. Of the 8091 patients, 57.94% were men and 42.06% were women. The mean age was 59.50 ± 16.11 years. The rate of death within 1 and 3 months was 10.67% and 29.16%, respectively. During the past 20 years, early mortality declined significantly. The common causes of early death were non-Hodgkin lymphoma and other infectious and parasitic diseases, including human immunodeficiency virus. Our results showed that gender, age at diagnosis, ethnicity, histological subtype, marital status, tumor location, surgery, radiotherapy, and chemotherapy were associated with early mortality within 1 or 3 months.
CONCLUSION: The rate of early mortality has declined significantly during the past 20 years. The risk factors for early mortality within 1 or 3 months after a PCNSL diagnosis included advanced age, male gender, black race, frontal lobe location, unmarried, diffuse large B-cell lymphoma, no surgery, no chemotherapy, and no radiotherapy.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Early mortality; Primary central nervous system lymphoma; Risk factor; SEER; Surveillance, Epidemiology, and End Results

Year:  2020        PMID: 32251807     DOI: 10.1016/j.wneu.2020.03.150

Source DB:  PubMed          Journal:  World Neurosurg        ISSN: 1878-8750            Impact factor:   2.104


  3 in total

1.  Diagnosis, treatment, and outcome of primary CNS lymphoma-a single-center experience.

Authors:  Joakim Wismann; Rune Hørlykke Sommer-Sørensen; Mikkel Seremet Kofoed; Bo Halle; Christian Bonde Pedersen; Mette Katrine Schulz; Mads Hjortdal Grønhøj; Thomas Stauffer Larsen; Michael Boe Møller; Frantz Rom Poulsen
Journal:  Acta Neurochir (Wien)       Date:  2022-03-07       Impact factor: 2.216

2.  Development and validation of a nomogram prediction model for early mortality in patients with primary malignant cardiac tumors.

Authors:  Shaojun Wang; Hui Jing; Zhiyong Yang
Journal:  Ann Transl Med       Date:  2021-11

3.  The PI3K/AKT/mTOR signaling pathway is aberrantly activated in primary central nervous system lymphoma and correlated with a poor prognosis.

Authors:  Xiaowei Zhang; Yuchen Wu; Xuefei Sun; Qu Cui; Xueyan Bai; Gehong Dong; Zifen Gao; Yaming Wang; Chunji Gao; Shengjun Sun; Nan Ji; Yuanbo Liu
Journal:  BMC Cancer       Date:  2022-02-20       Impact factor: 4.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.